REFERENCES
- Giovanni A, Mariotti C, Ripa E, Scassellati-Sforzolini B. Indocyanine green angiographic findings in serpiginous choroidopathy. Br J Ophthalmol. 1996; 80: 536–540, [CSA]
- Hamilton A M, Bird A C. Geographic choroidopathy. Br J Ophthalmol. 1974; 58: 784–788, [PUBMED], [INFOTRIEVE]
- King D G, Grizzard W S, Sever R J, Espinoza L. Serpiginous choroidopathy associated with elevated factor VIII—Von Willebrand factor antigen. Retina. 1990; 10: 97–101, [PUBMED], [INFOTRIEVE]
- Jampol L M, Orth D, Daily M J, Rabb M F. Subretinal neovascularisation with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979; 88: 683–689, [PUBMED], [INFOTRIEVE]
- Wojno T, Meredith T A. Unusual findings in serpiginous choroiditis. Am J Ophthalmol. 1982; 94: 650–655, [PUBMED], [INFOTRIEVE]
- Hooper P L, Kaplan H J. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 1991; 98: 944–951, [PUBMED], [INFOTRIEVE]
- Federman J L, Gouras P, Schubert H, . Inflammations of the retina. Textbook of ophthalmology, 1st ed., S M Podos, M Yanoff, et al. Mosby, Barcelona 1994; 10: 21–10, 22
- Akpek E K, Jabs D A, Tessler H H, et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology 2002; 109(8)1506–1513, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Laatikainen L, Erkkila H. Serpiginous choroiditis. Br J Ophthalmol. 1974; 58: 777–783, [PUBMED], [INFOTRIEVE]
- Becquet F, Cohen S Y, Coscas G. Choroidit serpigeneuse. J F Ophtalmol. 1992; 4: 288–298
- Friberg T R. Serpiginous choroiditis with branch vein occlusion and bilateral periphlebitis. Arch Ophthalmol. 1988; 106: 585–586, [PUBMED], [INFOTRIEVE]
- Tigh H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 1997; 112(3)1017–1021, [CSA]
- Gresser I. Biologic effects of interferons. J Invest Dermatol. 1990; 95: 66–71, [CROSSREF]
- Tilg H, Kaser A. Interferons and their role in inflammation. Curr Pharm Des. 1999; 5: 771–785, [PUBMED], [INFOTRIEVE], [CSA]
- Kötter I, Eckstein A K, Stubiger N, et al. Treatment of ocular symptoms of Behcet's disease with interferon alpha-2a: a pilot study. Br J Ophthalmol. 1998; 82: 488–494, [CSA]
- Kötter I, Zierhut M, Eckstein A K, et al. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol. 2003; 87: 423–431, [CROSSREF], [CSA]
- Azizlerli G, Sarica R, Kose A, et al. Interferon alfa-2a in the treatment of Behcet's disease. Dermatology. 1996; 192: 239–241, [PUBMED], [INFOTRIEVE]
- Bloch-Michel E, Nussenblatt R B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987; 103: 234–235, [PUBMED], [INFOTRIEVE]
- Anonymous. Argon laser photocoagulation for idiopathic neovascularization. Results of a randomized clinical trial. Arch Ophthalmol. 1983; 101(9)1358–1361
- Jampol L M, Orth D, Daily M J, Rabb M F. Subretinal neovascularization with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979; 88: 683–689, [PUBMED], [INFOTRIEVE]
- Martidis A, Miller D G, Ciulla T A, et al. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther. 1999; 15: 425–428, [PUBMED], [INFOTRIEVE], [CSA]
- Sanislo S R, Lowder C Y, Kauiser P K, et al. Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis. Am J Ophthalmol. 2000; 130(6)724–731, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Priya K, Hadhavan H N, Reiser B J, et al. Association of herpesviruses in the aqueous humor of patients with serpiginous choroiditis: apolymerase chain reaction-based study. Ocul Immunol Inflamm. 2002; 10(4)235–238, [CROSSREF], [CSA]
- Ciardella A P, Donsoff I M, Guyer D R, et al. Antiangiogenesis agents. Ophthalmol Clin North Am. 2002; 15(4)453–458, [PUBMED], [INFOTRIEVE], [CSA]